Aster Capital Management (DIFC) Ltd
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 2040915
DUBAI, C0
Position in JAZZ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$26,467
-$3,623 QoQ
Shares Held
140
-20.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aster Capital Management (DIFC) Ltd holds $2,069,231 across 43 Biotechnology names. JAZZ ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
182,089 | $1,396,622 | |
| 2 | ANAB |
Anaptysbio, Inc
|
5,218 | $192,926 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
260 | $83,769 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
2,954 | $70,393 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
734 | $41,463 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
550 | $41,299 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
140 | $26,467 | |
| 8 | EXEL |
Exelixis, Inc.
|
534 | $22,903 |
All Filings in JAZZ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,467 | 140 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,090 | 177 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,757 | 332 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $46,374 | 437 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,411,957 | 11,373 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||